Furthermore, patients with ECOG PS = 1, pathological type of ADC, KRAS mutation in exon 2, prior treatment ≥1 line, or number of metastases ≥3 received a greater ORR and PFS benefit (Supplementary Table 1). Here, KRAS is linked to AIDS dementia complex.